Osteoarthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 45 years or older.
- People with a body mass index (a measure of body weight relative to height) between 18 and 35.
- People who have a known diagnosis of Knee Osteoarthritis and have experienced mobility difficulties and joint discomfort related to it for at least 6 months, with symptoms present within the last 3 months.
- People who are willing to avoid foods that are high in Chondroitin Sulfate — such as animal cartilage, bones, or products like gelatin — for the full length of the study.
- People who are willing to stop taking any supplements that contain Chondroitin Sulfate for the full length of the study.
- People who are able to read and understand English.
- People who are able to read, understand, and sign a consent form agreeing to participate.
- People who own a personal smartphone and are willing to download an app called "Chloe by People Science."
- People who are able to receive product deliveries at a United States address.
- People who are able to complete all study activities over a period of up to 16 weeks.
Who may not be able to join:
- People who do not own a personal smartphone, do not have internet access, or are unwilling to download the Chloe app.
- People who have taken a Chondroitin Sulfate supplement in the 3 months before joining the study.
- People who have been regularly taking other joint health supplements — such as glucosamine, hyaluronic acid, or collagen peptides — for at least 4 weeks before joining the study.
- People who have received steroid injections directly into a joint or through a vein in the last 3 months.
- People who have taken part in another clinical trial or received an experimental treatment within 30 days before joining this study.
- People who have a self-reported inflammatory joint condition such as Rheumatoid Arthritis, Gout, or Infectious Arthritis.
- People who have a serious ongoing condition affecting the lungs, liver, heart, or kidneys (high blood pressure alone does not exclude someone).
- People who have had knee surgery in the 3 months before the study starts, or who have knee surgery planned during the study period.
- People who currently have a diagnosis of Alcohol Use Disorder or Substance Use Disorder.
- People who are currently pregnant, planning to become pregnant within the next 20 weeks, or who are breastfeeding.
- People who have an artificial knee joint (knee prosthesis).
- People who have any other significant illness or condition that the lead study doctor believes could affect participation or study results (confirm with trial site).
- People who have a known allergy or sensitivity to any of the following ingredients: Chondroitin Sulfate, Maltodextrin, Mannitol, Magnesium Stearate, Silicon Dioxide, Microcrystalline Cellulose, or Talc.
- People who have a known sensitivity or intolerance to wheat or gluten.
- People who, for any reason, the lead study doctor considers unlikely to be able to follow the study requirements (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Noah Craft, MD, PhD, People Science
Phone: +4915163496903
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
MyCondro's effectiveness
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.